Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive
68Ga-NOTA-MAL-MZHER2 Affibody: A feasible PET tracer for the noninvasive detection of lesions overexpressing HER2 in advanced gastric cancer patients and its utility in monitoring therapeutic response
Xiaoyi Guo, Nina Zhou, Chang Liu, Yuping Xu, Mi Yang, Hua Zhu, Lin Shen and Zhi Yang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 442;
Xiaoyi Guo
1Peking university Beijing China
Nina Zhou
2Peking University Cancer Hospital Beijing China
Chang Liu
1Peking university Beijing China
Yuping Xu
3Jiangsu Key Laboratory of Molecular Nuclear Medicine Jiangsu China
Mi Yang
3Jiangsu Key Laboratory of Molecular Nuclear Medicine Jiangsu China
Hua Zhu
4Beijing Cancer Hospital Beijing China
Lin Shen
1Peking university Beijing China
Zhi Yang
5Peking University Cancer Hospital & Institute Beijing China
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
68Ga-NOTA-MAL-MZHER2 Affibody: A feasible PET tracer for the noninvasive detection of lesions overexpressing HER2 in advanced gastric cancer patients and its utility in monitoring therapeutic response
Xiaoyi Guo, Nina Zhou, Chang Liu, Yuping Xu, Mi Yang, Hua Zhu, Lin Shen, Zhi Yang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 442;
68Ga-NOTA-MAL-MZHER2 Affibody: A feasible PET tracer for the noninvasive detection of lesions overexpressing HER2 in advanced gastric cancer patients and its utility in monitoring therapeutic response
Xiaoyi Guo, Nina Zhou, Chang Liu, Yuping Xu, Mi Yang, Hua Zhu, Lin Shen, Zhi Yang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 442;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.